# Bipolar II Depression: Lithium, SSRI, or the Combination

> **NCT00276965** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 139 (actual)

## Conditions studied

- Bipolar Disorder
- Depression

## Interventions

- **DRUG:** Sertraline
- **DRUG:** Lithium carbonate

## Key facts

- **NCT ID:** NCT00276965
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2012-03
- **Final completion:** 2012-07
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2013-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276965, "Bipolar II Depression: Lithium, SSRI, or the Combination". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00276965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*